• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非神经元型戈谢病的影像学:定量成像及疾病累及情况综合评估的最新进展

Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement.

作者信息

Degnan Andrew J, Ho-Fung Victor M, Ahrens-Nicklas Rebecca C, Barrera Christian A, Serai Suraj D, Wang Dah-Jyuu, Ficicioglu Can

机构信息

Department of Radiology, Children's Hospital of Philadelphia, 3401 Civic Center Blvd., Philadelphia, PA, 19104, USA.

Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.

出版信息

Insights Imaging. 2019 Jul 10;10(1):70. doi: 10.1186/s13244-019-0743-5.

DOI:10.1186/s13244-019-0743-5
PMID:31289964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6616606/
Abstract

Gaucher disease is an inherited metabolic disorder resulting in deficiency of lysosomal enzyme β-glucocerebrosidase causing the accumulation of abnormal macrophages ("Gaucher cells") within multiple organs, most conspicuously affecting the liver, spleen, and bone marrow. As the most common glycolipid metabolism disorder, it is important for radiologists encountering these patients to be familiar with advances in imaging of organ and bone marrow involvement and understand the role of imaging in clinical decision-making. The recent advent of commercially available, reliable, and reproducible quantitative MRI acquisitions to measure fat fractions prompts revisiting the role of quantitative assessment of bone marrow involvement. This manuscript reviews the diverse imaging manifestations of Gaucher disease and discusses more optimal quantitative approaches to ascertain solid organ and bone marrow involvement with an emphasis on future applications of other quantitative methods including elastography.

摘要

戈谢病是一种遗传性代谢紊乱疾病,会导致溶酶体酶β-葡萄糖脑苷脂酶缺乏,进而引起多个器官内异常巨噬细胞(“戈谢细胞”)的蓄积,最明显的是影响肝脏、脾脏和骨髓。作为最常见的糖脂代谢紊乱疾病,对于接触这些患者的放射科医生而言,熟悉器官和骨髓受累的影像学进展并了解影像学在临床决策中的作用非常重要。近期出现了可用于测量脂肪分数的商用、可靠且可重复的定量MRI采集方法,这促使人们重新审视骨髓受累定量评估的作用。本文综述了戈谢病的各种影像学表现,并讨论了用于确定实体器官和骨髓受累情况的更优化定量方法,重点是包括弹性成像在内的其他定量方法的未来应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/7920904d0401/13244_2019_743_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/a66cca2d3fb2/13244_2019_743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/b2ccdf4f91b4/13244_2019_743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/3bcfd2ee1af4/13244_2019_743_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/b1c400fdf38e/13244_2019_743_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/32947f0504c5/13244_2019_743_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/5e9a372efea2/13244_2019_743_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/b7d365dbc9e7/13244_2019_743_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/c273656c3568/13244_2019_743_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/53a49acaccb6/13244_2019_743_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/7920904d0401/13244_2019_743_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/a66cca2d3fb2/13244_2019_743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/b2ccdf4f91b4/13244_2019_743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/3bcfd2ee1af4/13244_2019_743_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/b1c400fdf38e/13244_2019_743_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/32947f0504c5/13244_2019_743_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/5e9a372efea2/13244_2019_743_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/b7d365dbc9e7/13244_2019_743_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/c273656c3568/13244_2019_743_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/53a49acaccb6/13244_2019_743_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4e/6616606/7920904d0401/13244_2019_743_Fig10_HTML.jpg

相似文献

1
Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement.非神经元型戈谢病的影像学:定量成像及疾病累及情况综合评估的最新进展
Insights Imaging. 2019 Jul 10;10(1):70. doi: 10.1186/s13244-019-0743-5.
2
The Spectrum of Neurological Manifestations Associated with Gaucher Disease.与戈谢病相关的神经学表现谱
Diseases. 2017 Mar 2;5(1):10. doi: 10.3390/diseases5010010.
3
Clinical manifestations and management of Gaucher disease.戈谢病的临床表现与治疗
Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):157-64. doi: 10.11138/ccmbm/2015.12.2.157. Epub 2015 Oct 26.
4
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.一种新型葡萄糖脑苷脂酶伴侣可降低戈谢病和帕金森综合征患者诱导多能干细胞衍生的多巴胺能神经元中的α-突触核蛋白和糖脂水平。
J Neurosci. 2016 Jul 13;36(28):7441-52. doi: 10.1523/JNEUROSCI.0636-16.2016.
5
Gaucher disease.戈谢病
J Clin Exp Hepatol. 2014 Mar;4(1):37-50. doi: 10.1016/j.jceh.2014.02.005. Epub 2014 Apr 21.
6
Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.戈谢病骨表现的闪烁成像有作用吗?文献综述。
Nuklearmedizin. 2008;47(6):239-47.
7
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.小儿非神经元型戈谢病:临床表现、诊断与评估。共识声明。
Eur J Pediatr. 2004 Feb;163(2):58-66. doi: 10.1007/s00431-003-1362-0. Epub 2003 Dec 16.
8
Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.将肝硬度与戈谢病 1 型(GD1)患者疾病严重程度评分系统(DS3)值相关联。
Mol Genet Metab. 2018 Mar;123(3):357-363. doi: 10.1016/j.ymgme.2017.10.013. Epub 2018 Jan 5.
9
An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease.对taliglucerase alfa治疗戈谢病患者潜在益处的循证综述。
Core Evid. 2012;7:15-20. doi: 10.2147/CE.S20201. Epub 2012 May 4.
10
Jaw involvement in Gaucher disease: a not-so-uncommon feature of a rare disease.颌骨受累在戈谢氏病中的表现:一种罕见疾病的并非少见的特征。
BMJ Case Rep. 2021 Nov 16;14(11):e244298. doi: 10.1136/bcr-2021-244298.

引用本文的文献

1
Gaucher disease, state of the art and perspectives.戈谢病:现状与展望
J Intern Med. 2025 Sep;298(3):155-172. doi: 10.1111/joim.20114. Epub 2025 Jul 3.
2
Recent developments in translational imaging of in vivo gene therapy outcomes.体内基因治疗效果的转化成像最新进展。
Mol Ther. 2025 Jun 4;33(6):2548-2564. doi: 10.1016/j.ymthe.2024.12.049. Epub 2024 Dec 30.
3
A Real-World Investigation of MRI Changes in Bone in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: The EIROS Study.用维拉苷酶α治疗的1型戈谢病患者骨骼MRI变化的真实世界研究:EIROS研究

本文引用的文献

1
Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.肝脏疾病中的定量弹性成像方法:当前证据与未来方向
Radiology. 2018 Mar;286(3):738-763. doi: 10.1148/radiol.2018170601.
2
Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.将肝硬度与戈谢病 1 型(GD1)患者疾病严重程度评分系统(DS3)值相关联。
Mol Genet Metab. 2018 Mar;123(3):357-363. doi: 10.1016/j.ymgme.2017.10.013. Epub 2018 Jan 5.
3
Marrow adipose tissue imaging in humans.人体骨髓脂肪组织成像。
J Clin Med. 2024 May 16;13(10):2926. doi: 10.3390/jcm13102926.
4
Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease.肝脾戈谢病的多参数磁共振成像。
Abdom Radiol (NY). 2024 Sep;49(9):3069-3077. doi: 10.1007/s00261-024-04293-w. Epub 2024 Apr 20.
5
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy.接受低剂量长期酶替代疗法的1型戈谢病患者定量化学位移成像的骨生物标志物
J Clin Med. 2023 Mar 13;12(6):2220. doi: 10.3390/jcm12062220.
6
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.神经元型戈谢病:超越溶酶体功能障碍
Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022.
7
Current and emerging pharmacotherapy for Gaucher disease in pediatric populations.儿童人群中戈谢病的当前和新兴药物治疗。
Expert Opin Pharmacother. 2021 Aug;22(11):1489-1503. doi: 10.1080/14656566.2021.1902989. Epub 2021 Mar 25.
Bone. 2019 Jan;118:69-76. doi: 10.1016/j.bone.2018.01.009. Epub 2018 Jan 10.
4
Contrast-enhanced US Assessment of Focal Liver Lesions in Children.超声造影评估儿童肝脏局灶性病变
Radiographics. 2017 Oct;37(6):1632-1647. doi: 10.1148/rg.2017170073.
5
Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment.肝脏、骨髓和脾脏戈谢瘤中的铁储存反映了接受治疗的1型戈谢病患者的残留疾病情况。
Br J Haematol. 2017 Nov;179(4):635-647. doi: 10.1111/bjh.14915. Epub 2017 Sep 14.
6
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.使用磁共振成像测量肝脏质子密度脂肪分数的线性、偏差和精密度:一项荟萃分析
Radiology. 2018 Feb;286(2):486-498. doi: 10.1148/radiol.2017170550. Epub 2017 Sep 11.
7
Quantitative MRI and spectroscopy of bone marrow.骨髓的定量 MRI 和波谱学。
J Magn Reson Imaging. 2018 Feb;47(2):332-353. doi: 10.1002/jmri.25769. Epub 2017 Jun 1.
8
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.戈谢病与帕金森症之间的复杂关系:来自一种罕见疾病的见解
Neuron. 2017 Feb 22;93(4):737-746. doi: 10.1016/j.neuron.2017.01.018.
9
Proton Density Fat Fraction Measurements at 1.5- and 3-T Hepatic MR Imaging: Same-Day Agreement among Readers and across Two Imager Manufacturers.1.5T 和 3T 肝脏 MR 成像的质子密度脂肪分数测量:读者之间和两个成像仪制造商之间的当日协议。
Radiology. 2017 Jul;284(1):244-254. doi: 10.1148/radiol.2017161786. Epub 2017 Feb 17.
10
Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease. Possible impact of reporting experience.用于评估戈谢病疾病严重程度的骨髓负荷(BMB)评分的观察者内和观察者间变异性。报告经验的可能影响。
Blood Cells Mol Dis. 2018 Feb;68:121-125. doi: 10.1016/j.bcmd.2016.11.004. Epub 2016 Nov 14.